Physician profile
Arthur Benjamin
NPI 1487682423
$3,752.25
in general payments reported to CMS, 2019-2025
27 companies · $342 in 2025
The $342 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $770 · 2020: $365 · 2021: $563 · 2022: $492 · 2023: $812 · 2024: $408 · 2025: $342.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,563.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,562.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $520.54 | 2019-2021 | |
| New World Medical,INC. | $509.68 | 2019-2023 | |
| Alcon Vision LLC | $503.47 | 2019-2025 | Ora System Verifeye, Centurion, Clareon Panoptix Pro |
| Sun Pharmaceutical Industries INC. | $247.01 | 2019-2025 | Cequa |
| Sight Sciences, INC. | $198.31 | 2021-2023 | Omni Surgical System |
| Johnson & Johnson Surgical Vision, INC. | $191.72 | 2019-2024 | Catalys System, Tecnis Simplicity |
| Ivantis, INC | $190.14 | 2019-2020 | |
| Bausch & Lomb Americas INC. | $144.97 | 2022-2025 | Miebo, Envista Mx60 Iol, Envista Envy Iol |
| Rxsight INC | $144.67 | 2022-2024 | Rxsight Contact Lens, Light Adjustable Lens (Lal), Rxsight Injector Cartridge |
| Dompe US, INC. | $140.29 | 2023-2025 | Oxervate |
| Biotissue Holdings INC. | $129.49 | 2022-2025 | |
| Mallinckrodt Hospital Products INC. | $114.69 | 2021-2022 | |
| Nova Eye, INC. | $110.22 | 2024 | |
| Carl Zeiss Meditec USA, INC. | $93.48 | 2023 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $83.49 | 2019-2020 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tarsus Pharmaceuticals, INC. | $65.74 | 2024-2025 | Xdemvy |
| Horizon Therapeutics Plc | $58.16 | 2021 | |
| Akorn Operating Company LLC | $52.63 | 2021 | |
| Oyster Point Pharma, INC. | $44.19 | 2022-2025 | Tyrvaya |
| Astellas Pharma US INC | $39.75 | 2024 | Izervay |
| Glaukos Corporation | $35.61 | 2019 | |
| Abbvie INC. | $27.94 | 2022 | |
| Rayner Intraocular Lenses Limited | $26.36 | 2024 | Rayone Spheric, Rayone Aspheric, Rayone Emv |
| Novartis Pharmaceuticals Corporation | $21.61 | 2022 | |
| Eyevance Pharmaceuticals LLC | $20.62 | 2019 | |
| Akorn, INC. | $18.85 | 2020 | |
| Thea Pharma INC. | $18.62 | 2024 | Iyuzeh |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arthur Benjamin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.